A Phase IIa Clincal Trial Treating Patients With Early Stage Breast Cancer for Not Exceding 7 Days Prior Surgery With PTS(para-toluenesulfonamide injection), A Novel Local Invasive Anticancer Drug, Administered By Local and Intratumoral Injection Therapy

Trial Profile

A Phase IIa Clincal Trial Treating Patients With Early Stage Breast Cancer for Not Exceding 7 Days Prior Surgery With PTS(para-toluenesulfonamide injection), A Novel Local Invasive Anticancer Drug, Administered By Local and Intratumoral Injection Therapy

Completed
Phase of Trial: Phase II

Latest Information Update: 22 Apr 2016

At a glance

  • Drugs P-toluenesulfonamide (Primary)
  • Indications Breast cancer
  • Focus Therapeutic Use
  • Sponsors Beijing Vision Drugs Development
  • Most Recent Events

    • 21 Aug 2015 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top